Hypertrophic cardiomyopathy patients with sustained ventricular tachycardia
Conditions
Interventions
Ablation group (patients who underwent catheter ablation):NA
AAD group (patients who received AAD therapy):NA
Sponsors
The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: The study population includes 28 HCM patients with sustained VT, age 18 to 80 years old.
Exclusion criteria
Exclusion criteria: Patients with prior VT ablation, Patients with malignant tumors or hematological diseases with a life expectancy of less than 1 year, Patients with incomplete data, Patients who didn’t visit for routine follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VT recurrence; | — |
Secondary
| Measure | Time frame |
|---|---|
| hospital admission due to cardiovascular (CV) cause;CV cause-related mortality, or heart transplantation;the composite endpoint of VT recurrence, hospital admission due to CV cause, CV cause-related mortality, or heart transplantation.; | — |
Countries
China
Contacts
Public ContactZhang Fengxiang
The First Affiliated Hospital of Nanjing Medical University
Outcome results
None listed